Key Statistics
Market Cap$249.91M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.38
52W High$3.62
52W Low$0.49
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees15
Price Performance
1 Week+5.02%
3 Month+75.48%
1 Year+278.30%
FinancialsAnnual · QuiverQuant
Revenue$1.16M
Assets$16.06M
Liabilities$4.19M
Net Income$23.96M loss
About
Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of chronic pain. The company is headquartered in Boston, Massachusetts.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze CNTX with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.